Maximizing the Alzheimer's Disease Neuroimaging Initiative II
Year: 2009
Type: article
Source: Alzheimer s & Dementia
Language: English
Subfield: Psychiatry and Mental health
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funders: Alzheimer's Association, Bristol-Myers Squibb Foundation, Abbott Laboratories, Eli Lilly and Company, Pfizer, AstraZeneca, GlaxoSmithKline, Merck, Wyeth, F. Hoffmann-La Roche, Schering-Plough, Synarc, Elan, Innogenetics, Bayer Schering, National Institutes of Health, Genentech, Johnson and Johnson, GE Healthcare, University of California, San Diego
OpenAlex ID: W1978763979